Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Bone marrow is the preferred site of memory CD4+ T cell proliferation during recovery from sepsis
Tomasz Skirecki, Patrycja Swacha, Grażyna Hoser, Jakub Golab, Dominika Nowis, Ewa Kozłowska
Tomasz Skirecki, Patrycja Swacha, Grażyna Hoser, Jakub Golab, Dominika Nowis, Ewa Kozłowska
View: Text | PDF
Research Article Immunology Infectious disease

Bone marrow is the preferred site of memory CD4+ T cell proliferation during recovery from sepsis

  • Text
  • PDF
Abstract

Sepsis survivors suffer from increased vulnerability to infections, and lymphopenia presumably contributes to this problem. The mechanisms of the recovery of memory CD4+ T cells after sepsis remain elusive. We used the cecal ligation and puncture mouse model of sepsis to study the restoration of the memory CD4+ T cells during recovery from sepsis. Then, adoptive transfer of antigen-specific naive CD4+ T cells followed by immunization and BrdU labeling were performed to trace the proliferation and migration of memory CD4+ T cells. We revealed that the bone marrow (BM) is the primary site of CD4+ memory T cell homing and proliferation after sepsis-induced lymphopenia. Of interest, BM CD4+ T cells had a higher basal proliferation rate in comparison with splenic T cells. These cells also show features of resident memory T cells yet have the capacity to migrate outside the BM niche and engraft secondary lymphoid organs. The BM niche also sustains viability and functionality of CD4+ T cells. We also identified IL-7 as the major inducer of proliferation of the BM memory CD4+ T cells and showed that recombinant IL-7 improves the recovery of these cells. Taken together, we provide data on the mechanism and location of memory CD4+ T cell proliferation during recovery from septic lymphopenia, which are of relevance in studying immunostimulatory therapies in sepsis.

Authors

Tomasz Skirecki, Patrycja Swacha, Grażyna Hoser, Jakub Golab, Dominika Nowis, Ewa Kozłowska

×

Figure 6

IL-7 drives proliferation of CD4+CD44+CD62L– T cells in the BM after sepsis.

Options: View larger image (or click on image) Download as PowerPoint
IL-7 drives proliferation of CD4+CD44+CD62L– T cells in the BM after sep...
(A) Kinetics of IL-7 levels in the plasma and BM after sepsis. IL-7 concentration was measured in the sera and BM supernatants of healthy and postseptic mice at different time points (n = 6–8). For plasma: #P < 0.05 between 72 hours and 7 days. For BM: *P < 0.05, ***P < 0.001, and ****P < 0.0001 using ANOVA multiple-comparisons with Tukey’s post hoc test. (B) Confocal microscopy photographs of the BM sections show IL-7 (red) and CD4+ T cells (green) (representative of n = 4). Scale bar: 50 μm. (C) IL-7 is responsible for the proliferation of CD4+CD44+CD62L– T cells after sepsis. Post-CLP mice received anti–IL-7R (anti-CD127) antibody on days 5 and 6 of sepsis and a bolus of BrdU on day 6. BrdU incorporation was evaluated by FACS 24 hours later. Representative plots are shown. Box-and-whiskers plot presents p25-p75 (box), mean, and p10-p90 (whiskers). Dashed line shows range of BrdU+CD4+CD44+CD62L– cells in control mice. *P < 0.05 (n = 6 per group) using Student’s t test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts